Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Polyphenon E Against Various Endpoints of Actinic Keratosis Pathobiology
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2018
Price :
$35
*
At a glance
- Drugs Polyphenon E (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 09 Sep 2014 New trial record